As psychedelic research increases, and a number of policy developments across the likes of the US, Canada and Australia are now enabling the delivery of psychedelic...
University of Cincinnati researchers have examined post-treatment journals kept by participants in a smoking cessation study that found psychedelics were effective in helping some people quit...
Over 100 academics, psychologists, anthropologists and activists have signed a manifesto launched by the Chacruna Institute for Psychedelic Plant Medicines calling for an end to police...
PharmaDrug Inc.
By combining AI, clinical testing and computer analysis of vast amounts of biomedical knowledge and electronic health records, researchers at Case Western Reserve University have found...
Awakn Life Sciences has signed its first Licensing Partnership agreement in Europe with a healthcare consortium.
The US Food and Drug Administration (FDA) has given IND approval for a Phase 2b study of a synthetic formulation of 5-MeO-DMT – BPL-003.
In two letters seen by Psychedelic Health, a cross-party group of MEPs has expressed concern over the lack of progress with the medical use of psychedelics...
Doug Drysdale, CEO of Cybin Inc.,
In what marks a significant finding in the advancement of psychedelic research, a new study has demonstrated that the location of serotonin 2A receptors (5-HT2A) is...